Few & Far Between: Conversations from the Front Lines of Drug Development

Episode 18: Karen Petrou and David Brint - BioBonds

Listen Later

On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.

...more
View all episodesView all episodes
Download on the App Store
Few & Far Between: Conversations from the Front Lines of Drug DevelopmentBy Chris O'Brien
  • 5
  • 5
  • 5
  • 5
  • 5

5

12 ratings

More shows like Few & Far Between: Conversations from the Front Lines of Drug Development

View all
The Readout Loud by STAT

The Readout Loud

316 Listeners